Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01411917 · ClinicalTrials.gov registry record · NA
Transversus Abdominis Plane Blocks for Ileostomy Takedown: A Prospective Study
A NA study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT01411917 is a NA study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 69 participants.
The verdict
NCT01411917, a NA study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
Consenting subjects will be randomized to receive injection of bupivacaine or placebo before surgery for ileostomy takedown (injection administered after general anesthesia has been administered). Pain and side effects will be assessed periodically after surgery using the verbal Numeric Rating pain Scores, including at the timepoint of 24 hours after surgery. All subjects in this study will be given toradol to ensure adequate pain control.
Interventions
- PROCEDURE Transversus abdominis plane block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2011-08 |
| Est. Completion | 2015-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01411917
The ClinicalTrials.gov registry entry for NCT01411917 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transversus abdominis plane block is the first listed.
NCT01411917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01411917 about?
NCT01411917 is a clinical study titled "Transversus Abdominis Plane Blocks for Ileostomy Takedown: A Prospective Study". Consenting subjects will be randomized to receive injection of bupivacaine or placebo before surgery for ileostomy takedown (injection administered after general anesthesia has been administered). Pain and side effects will be assessed periodically after surgery using the verbal Numeric Rating pain ...
What is the current status of trial NCT01411917?
This trial is currently terminated. It is a NA study. The enrollment target is 69 participants. The study started on 2011-08. Estimated completion is 2015-11-30.
What interventions are being tested in trial NCT01411917?
The interventions under investigation include: Transversus abdominis plane block (PROCEDURE).
Who is sponsoring clinical trial NCT01411917?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.